The concomitant use of insulin and a DPP-4 inhibitor was recommended by a joint position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) in the therapeutic algorithm for T2DM management [8]. This evidence concerns the gene DPP4 and type 2 diabetes mellitus.